Carcinoma: all 6,719 studies
Page 51 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.
- Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the LiverCompletedNCT02288910
- Eradication of Malignant Carcinoma in the Breast TissueCompletedNCT02286778Phase 2/3
- One-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal MicroscopyCompletedNCT02285790Not applicable
- Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume DefinitionStatus unknownNCT02285660Not applicable
- A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC PatientsTerminatedNCT02285543Phase 2
- Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line TherapyCompletedNCT02282579
- Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative ResectionStatus unknownNCT02281266Phase 4
- Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG)TerminatedNCT02279576Phase 2
- Dual-Energy CT in Patients With Head and Neck Squamous Cell CarcinomasCompletedNCT02279459
- BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial CarcinomaStatus unknownNCT02278978Phase 2
- Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast CancerCompletedNCT02278965Phase 1
- Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT02277197Phase 1
- Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell CarcinomaTerminatedNCT02277184Phase 1
- Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell CarcinomaWithdrawnNCT02272699Phase 2/3
- SAS in Patients With Bronchial CarcinomaStatus unknownNCT02270853Not applicable
- Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast CancerCompletedNCT02270372Phase 1
- Post-marketing Surveillance of DC Bead in Patients With Hepatocellular CarcinomaCompletedNCT02269995
- Neck Dissection Via a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynxCompletedNCT02269020Phase 1
- Efficacy and Safety Study of TLC388 to Advanced Hepatocellular CarcinomaTerminatedNCT02267213Phase 2
- A Phase I Evaluating Integration of HypofractionatedStudy Renal Ablative RadiotherapyCompletedNCT02264548Phase 1
- A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab in Head and Neck CancerCompletedNCT02262741Phase 1
- Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT02259647Not applicable
- Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or EsophagusTerminatedNCT02254044Phase 1
- A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular CarcinomaStatus unknownNCT02253511Phase 4
- Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02250599Phase 2
- Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal CarcinomaCompletedNCT02248805Phase 1
- Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3)CompletedNCT02248012Phase 2
- Investigating Patient Satisfaction With Oral Anti-Cancer TreatmentCompletedNCT02247583
- Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung CancerCompletedNCT02245100
- Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)Status unknownNCT02244502Phase 1/2
- Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular CarcinomaCompletedNCT02243384Not applicable
- Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell CarcinomaStatus unknownNCT02242929Phase 3
- Diffusion-Weighted Magnetic Resonance ImagingStatus unknownNCT02242786Phase 2
- Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT02240771Phase 2/3
- A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC)CompletedNCT02240433Phase 1
- 18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular CarcinomaStatus unknownNCT02238769
- Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal CarcinomaCompletedNCT02237924Phase 2
- Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and NeckTerminatedNCT02236936Phase 3
- Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific GenesCompletedNCT02236195Phase 2
- A Study of BBI503 in Adult Patients With Advanced Urologic MalignanciesWithdrawnNCT02232646Phase 2
- Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-LStatus unknownNCT02232490Phase 3
- Olaparib and Radiotherapy in Head and Neck CancerActive, not recruitingNCT02229656Phase 1
- IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)CompletedNCT02228954
- Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving EnzalutamideCompletedNCT02228265
- Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular CarcinomaWithdrawnNCT02227914Phase 1/2
- Olaparib and Radiotherapy in Inoperable Breast CancerCompletedNCT02227082Phase 1
- Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung CancerCompletedNCT02225405Phase 1
- Effects of Diet and Exercise on Ductal Carcinoma in SituCompletedNCT02224807Not applicable
- Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy SystemStatus unknownNCT02224547Phase 2
- SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACEActive, not recruitingNCT02221778Phase 2
- Immunotoxin in Peritoneal Carcinomatosis- ImmunoPeCa TrialCompletedNCT02219893Phase 1/2
- Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous LesionsCompletedNCT02217358Not applicable
- A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine CarcinomasStatus unknownNCT02215447Phase 2
- Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNAWithdrawnNCT02211027Phase 1
- A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular CarcinomaCompletedNCT02210182Phase 1
- Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the BladderActive, not recruitingNCT02202772Phase 1/2
- Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular CarcinomaCompletedNCT02202564Phase 2
- Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and NeckTerminatedNCT02201355Phase 1
- Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal CancerCompletedNCT02199171Phase 1
- Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc TauliCompletedNCT02199132
- Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs ObservationCompletedNCT02196961Phase 2
- HR Versus RFA for HCC in Patients With PHTStatus unknownNCT02192671Phase 3
- Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular CarcinomaCompletedNCT02191878Phase 1/2
- Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional StudyCompletedNCT02188901Not applicable
- Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal CancerStatus unknownNCT02188615Phase 2
- Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical StudyStatus unknownNCT02187315Phase 2
- CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)CompletedNCT02187302Phase 2
- Point in Time of Radiotherapy for Patients With Biochemical Recurrent Prostate CarcinomaStatus unknownNCT02181192Not applicable
- Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal CarcinomatosisCompletedNCT02179489Not applicable
- Window Trial 5-aza in HNSCC, T-tareCompletedNCT02178072Phase 1
- Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas CarcinomaCompletedNCT02172976Phase 2/3
- Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract CancerActive, not recruitingNCT02170090Phase 3
- HR Versus RFA for Early Stage HCCStatus unknownNCT02169765Phase 3
- Dual Energy CT vs Standard Triple Phase CT-A Randomised Control TrialCompletedNCT02160600Not applicable
- DNA Methylation Biomarkers and Metastasis of Gastric CarcinomaCompletedNCT02159339
- Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal CarcinomatosisCompletedNCT02158988Phase 3
- Video-Based Treatment Options for Basal Cell CarcinomaCompletedNCT02158650Not applicable
- Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and NeckCompletedNCT02158234Phase 1
- Quantitative Real-time Ultrasound Elastography for Characterisation of Liver TumorsCompletedNCT02156700
- Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)Status unknownNCT02156362Not applicable
- Identification of Breath Biomarkers in Head and Neck Squamous Cell CarcinomaSuspendedNCT02156180
- EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung CancerCompletedNCT02154399Phase 2
- Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive PatientsCompletedNCT02152943Phase 1
- LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 CirrhosisCompletedNCT02151864Phase 1
- Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular CarcinomaStatus unknownNCT02150317Not applicable
- Combination Treatment for Advanced Liver CancerWithdrawnNCT02149771Phase 3
- An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.Status unknownNCT02145312Phase 2
- Portal Hypertension and Liver Resection in Patients With Hepatocellular CarcinomaStatus unknownNCT02145013
- Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma PatientsWithdrawnNCT02143622Phase 1/2
- Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCCCompletedNCT02143492
- Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid TumorsCompletedNCT02143401Phase 1
- Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical TrialCompletedNCT02143388Phase 3
- Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan CriteriaStatus unknownNCT02138981Phase 4
- Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1WithdrawnNCT02129322Phase 2
- An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian FederationCompletedNCT02128334
- The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer StudyStatus unknownNCT02126189
- Pulsed Dye Laser in Treating Superficial Basal Cell CarcinomasCompletedNCT02125669Not applicable
- Neoadjuvant Chemotherapy in Epithelial Ovarian CancerStatus unknownNCT02125513Phase 2
- Adjuvant Radiotherapy Comparing TACE for Curative HCCStatus unknownNCT02125396Phase 3
- HOT: HIPEC in Ovarian Cancer as Initial TreatmentActive, not recruitingNCT02124421Phase 2